Fairfield Financial Advisors’s Pfizer PFE Stock Holding History

Fairfield Financial Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-173	Closed	-$4.58K	–	155
2024 Q4	$4.58K	Sell	173 -167	-49%	-$4.53K	﹤0.01%	226
2024 Q3	$9.83K	Buy	340 +5	+1%	+$146	﹤0.01%	225
2024 Q2	$9.37K	Buy	+335	New	+$9.22K	﹤0.01%	217
2023 Q4	$9.35K	Sell	325 -1,056	-76%	-$31.9K	﹤0.01%	244
2023 Q3	$45.8K	Sell	1,381 -1,048	-43%	-$37.1K	0.02%	144
2023 Q2	$89.1K	Sell	2,429 -597	-20%	-$23.2K	0.04%	103
2023 Q1	$122K	Sell	3,026 -75	-2%	-$3.24K	0.05%	87
2022 Q4	$159K	Buy	3,101 +70	+2%	+$3.36K	0.07%	73
2022 Q3	$133K	Buy	3,031 +749	+33%	+$36.4K	0.06%	78
2022 Q2	$120K	Buy	2,282 +315	+16%	+$16.1K	0.06%	80
2022 Q1	$102K	Buy	+1,967	New	+$102K	0.04%	87

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fairfield Financial Advisors's PFE Position: Q1 2025 in Review

Fairfield Financial Advisors sold out of Pfizer (PFE) in Q1 2025, closing a stake of 173 shares — an estimated $4.58K sold.

Fairfield Financial Advisors first reported a position in PFE in Q1 2022 and held it in 11 quarters. The position peaked at $159K in Q4 2022. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Fairfield Financial Advisors reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Fairfield Financial Advisors sold 173 Pfizer shares in Q1 2025, an estimated $4.58K.
Fairfield Financial Advisors first reported a position in Pfizer in Q1 2022 and held it in 11 quarters.
Fairfield Financial Advisors's Pfizer position peaked at $159K in Q4 2022.
2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Fairfield Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.